Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology

  • Svennberg, Emma
  • Han, Janet K.
  • Caiani, Enrico G.
  • Engelhardt, Sandy
  • Ernst, Sabine
  • Friedman, Paul
  • Garcia, Rodrigue
  • Ghanbari, Hamid
  • Hindricks, Gerhard
  • Man, Sharon H.
  • Narayan, Sanjiv M.
  • Ng, G. Andre
  • Noseworthy, Peter A.
  • Tjong, Fleur V. Y.
  • Millet Roig, José|||0000-0002-8879-003X
[EN] Aims Artificial intelligence (AI) has the potential to transform cardiac electrophysiology (EP), particularly in arrhythmia detection, procedural optimization, and patient outcome prediction. However, a standardized approach to reporting and understanding AI-related research in EP is lacking. This scientific statement aims to develop and apply a checklist for AI-related research reporting in EP to enhance transparency, reproducibility, and understandability in the field. Methods and results An AI checklist specific to EP was developed with expert input from the writing group and voted on using a modified Delphi process, leading to the development of a 29-item checklist. The checklist was subsequently applied to assess reporting practices to identify areas where improvements could be made and provide an overview of the state of the art in AI-related EP research in three domains from May 2021 until May 2024: atrial fibrillation (AF) management, sudden cardiac death (SCD), and EP lab applications. The EHRA AI checklist was applied to 31 studies in AF management, 18 studies in SCD, and 6 studies in EP lab applications. Results differed between the different domains, but in no domain reporting of a specific item exceeded 55% of included papers. Key areas such as trial registration, participant details, data handling, and training performance were underreported (<20%). The checklist application highlighted areas where reporting practices could be improved to promote clearer, more comprehensive AI research in EP. Conclusion The EHRA AI checklist provides a structured framework for reporting AI research in EP. Its use can improve understanding but also enhance the reproducibility and transparency of AI studies, fostering more robust and reliable integration of AI into clinical EP practice.; [GRAPHICS]; ., E.S. is supported by the Stockholm County Council (Clinical researcher appointment), the Swedish Research Council (DNR 2022-01466), the Swedish Heart and Lung foundation, CIMED, S.E. is supported by research grants from German Center for Cardiovascular Research (DZHK), the Carl-Zeiss Foundation in the project Multi-dimension AI. J Millet (e-cardiology) reports grant support PID2022-142514OB-I00 from Spanish Research Agency. Professor GA Ng reports grant support from the British Heart Foundation [Research Excellence Award (RE/24/13003) and Healthcare Innovation Fund (HI/C2/24/360038)], the National Institute for Health and Care Research Invention for Innovation Award (NIHR204553). F.V.Y.T. is supported by personal research grants from the Dutch Research Council (NWO), Amsterdam Cardiovascular Sciences, and Health Holland. J.R. acknowledges funding from the European Union-NextGenerationEU, fellowship RYC2021-031413-I from MCIN/AEI/10.13039/501100011033, and from the European Union "NextGenerationEU/PRTR" and from grants PID2021-128972OA-I00, CNS2023-143599 and PID2023-148975OB-I00, funded by MCIN/AEI/10.13039/501100011033. N.T. (HRS) is supported by NIH grants R01HL166759 and R01HL174440 and a grant from the Leducq Foundation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Prediction of atrial and ventricular arrhythmias using multiple cardiovascular risk-factor polygenic risk scores

  • Ramírez, Julia
  • van Duijvenboden, Stefan
  • Orini, Michele
  • Lambiase, Pier D.
  • Tinker, Andrew
  • Young, William J.
  • Munroe, Patricia B.
Background. Atrial fibrillation (AF) prediction improves by combining clinical scores with a polygenic risk score (PRS) for AF (AF-PRS), but there are limited studies of PRS for ventricular arrhythmia (VA) prediction. We assessed the value of including multiple PRS for cardiovascular risk factors (CV-PRS) for incident AF and VA prediction. Methods. We used 158,733 individuals of European ancestry from UK Biobank to build 3 models for AF: CHARGE-AF (AF1), AF1 + AF-PRS (AF2), AF2 + CV-PRS (AF3). Models for VA included sex and age (VA1), VA1 + coronary artery disease (CAD) PRS (CAD-PRS, VA2), and VA2 + CV-PRS (VA3), conducting separate analyses in subjects with and without ischemic heart disease (IHD). Performance was evaluated in individuals of European (N = 158,733), African (N = 7200), South Asian (N = 9241) and East Asian (N = 2076) ancestry from UK Biobank. Results. AF2 had a higher C-index than AF1 (0.762 vs 0.746, P < .001), marginally improving to 0.765 for AF3 (P < .001, including PRS for heart failure, electrocardiogram and cardiac magnetic resonance measures). In South Asians, AF2 C-index was higher than AF1 (P < .001). For VA, the C-index for VA2 was greater than VA1 (0.692 vs 0.681, P < .001) in Europeans, which was also observed in South Asians (P < .001). VA3 improved prediction of VA in individuals with IHD. Conclusion. CV-PRS improved AF prediction compared to CHARGE-AF and AF-PRS. A CAD-PRS improved VA prediction, while CV-PRS contributed in IHD. AF- and CAD-PRS were transferable to individuals of South Asian ancestry. Our results inform of the use of CV-PRS for personalized screening.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Unsupervised clustering of songle-lead ECGs associates with prevalent and incident heart failure in coronary artery disease

  • Madrid, Josseline
  • Young, William
  • van Duijvenboden, Stefan
  • Orini, Michele
  • Munroe, Patricia
  • Ramírez García, Julia*
  • Mincholé, Ana
Clinical consequences of coronary artery disease (CAD) are varied [e.g. atrial fibrillation (AF) and heart failure (HF)], and current risk stratification tools are ineffective. We aimed to identify clusters of individuals with CAD exhibiting unique pat-terns on the electrocardiogram (ECG) in an unsupervised manner and assess their association with cardiovascular risk. Methods and results Twenty-one ECG markers were derived from single-lead median-beat ECGs of 1928 individuals with CAD without a previous diagnosis of AF, HF, or ventricular arrhythmia (VA) from the imaging study in UK Biobank (CAD-IMG-UKB). An un-supervised clustering algorithm was used to group these markers into distinct clusters. We characterized each cluster according to their demographic and ECG characteristics, as well as their prevalent and incident risk of AF, HF, and VA(4-year median follow-up). Validation and association with prevalent diagnoses were performed in an independent cohort of 1644 individuals. The model identified two clusters within the CAD-IMG-UKB cohort. Cluster 1 (n = 359) exhibited pro-longed QRS duration and QT intervals, along with greater morphological variations in QRS and T-waves, compared with Cluster 2 (n = 1569). Cluster 1, relative to Cluster 2, had a significantly higher risk of incident HF [hazard ratio (HR):2.40, 95% confidence interval (CI): 1.51–3.83], confirmed by independent validation (HR: 1.77, CI: 1.31–2.41). It also showed a higher association with prevalent HF (odds ratio: 4.10, CI: 2.02–8.29), independent of clinical risk factors. Conclusion Our approach identified a cluster of individuals with CAD sharing ECG characteristics indicating HF risk, holding significant implications for targeted treatment and prevention enabling accessible large-scale screening.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

RoePINNs: An integration of advanced CFD solvers with Physics-Informed Neural Networks and application in arterial flow modeling

  • Orera, J.
  • Ramírez, J.
  • García-Navarro, P.
  • Murillo, J.
The characterization of forward and inverse problems describing blood flow dynamics plays a decisive role in numerous biomedical applications. These systems can be modeled using one-dimensional (1D) approaches leading to a hyperbolic system of equations with source terms. Their numerical discretization, associated to the spatial variation of mechanical and geometrical properties, requires advanced numerical solvers that ensure both stability and an accurate description of the dynamics of the system. In this work, we present RoePINNs, a hybrid framework for the embedding of advanced Computational Fluid Dynamics (CFD) solvers into Physics-Informed Neural Networks (PINNs), and give examples of application to Burgers’ equation as well as the propagation of nonlinear waves in elastic arteries, both under the presence of geometric-type source terms, for forward and inverse problems. We demonstrate that Augmented Riemann solvers can be incorporated into the PINN framework with straightforward adjustments to the hyperparameters, providing a promising alternative to automatic differentiation (AD), especially in cases where the solution exhibits strong nonlinearities and physical constraints are required. Benefits of the proposed RoePINN compared with the vanilla PINN based in AD are twofold: on the one hand, this hybrid approach employs numerical differentiation by means of support points in the surroundings of the collocation points, hence the robustness, generalization capacity and tunability of the PINNs are, in most cases, largely enhanced. On the other hand, the RoePINN incorporates the numerical solver, hence it is also capable of capturing sharp discontinuities with an order-of-magnitude improvement in accuracy compared with the vanilla version.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Using Genomics to Develop Personalized Cardiovascular Treatments

  • Sanghvi, Mihir M.
  • Young, William J.
  • Naderi, Hafiz
  • Burns, Richard
  • Ramírez, Julia
  • Bell, Christopher G.
  • Munroe, Patricia B.
Advances in genomic technologies have significantly enhanced our understanding of both monogenic and polygenic etiologies of cardiovascular disease. In this review, we explore how the utilization of genomic information is bringing personalized medicine approaches to the forefront of cardiovascular disease management. We describe how genomic data can resolve diagnostic uncertainty, support cascade screening, and inform treatment strategies. We discuss how genome-wide association studies have identified thousands of genetic variants associated with polygenic cardiovascular diseases, and how integrating these insights into polygenic risk scores can enhance personalized risk prediction beyond traditional clinical algorithms. We detail how pharmacogenomics approaches leverage genotype information to guide drug selection and mitigate adverse events. Finally, we present the paradigm-shifting approach of gene therapy, which holds the promise of being a curative intervention for cardiovascular conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology

  • Svennberg, Emma
  • Han, Janet K.
  • Caiani, Enrico G.
  • Engelhardt, Sandy
  • Ernst, Sabine
  • Friedman, Paul
  • Garcia, Rodrigue
  • Ghanbari, Hamid
  • Hindricks, Gerhard
  • Man, Sharon H.
  • Millet, José
  • Narayan, Sanjiv M.
  • Ng, G. André
  • Noseworthy, Peter A.
  • Tjong, Fleur V.Y.
  • Ramírez, Julia
  • Singh, Jagmeet P.
  • Trayanova, Natalia
  • Duncker, David
  • Tfelt Hansen, Jacob
  • Barker, Joseph
  • Casado-Arroyo, Ruben
  • Chatterjee, Neal A.
  • Conte, Giulio
  • Diederichsen, Søren Zöga
  • Linz, Dominik
  • Mahtani, Arun Umesh
  • Zorzi, Alessandro
Aims Artificial intelligence (AI) has the potential to transform cardiac electrophysiology (EP), particularly in arrhythmia detection, procedural optimization, and patient outcome prediction. However, a standardized approach to reporting and understanding AI-related research in EP is lacking. This scientific statement aims to develop and apply a checklist for AI-related research reporting in EP to enhance transparency, reproducibility, and understandability in the field. Methods and results An AI checklist specific to EP was developed with expert input from the writing group and voted on using a modified Delphi process, leading to the development of a 29-item checklist. The checklist was subsequently applied to assess reporting practices to identify areas where improvements could be made and provide an overview of the state of the art in AI-related EP research in three domains from May 2021 until May 2024: atrial fibrillation (AF) management, sudden cardiac death (SCD), and EP lab applications. The EHRA AI checklist was applied to 31 studies in AF management, 18 studies in SCD, and 6 studies in EP lab applications. Results differed between the different domains, but in no domain reporting of a specific item exceeded 55% of included papers. Key areas such as trial registration, participant details, data handling, and training performance were underreported (<20%). The checklist application highlighted areas where reporting practices could be improved to promote clearer, more comprehensive AI research in EP. Conclusion The EHRA AI checklist provides a structured framework for reporting AI research in EP. Its use can improve understanding but also enhance the reproducibility and transparency of AI studies, fostering more robust and reliable integration of AI into clinical EP practice.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Sudden cardiac death risk prediction from QT–RR adaptation time lag computed from exercise stress test ECG

  • Pérez, Cristina
  • Martínez, Juan Pablo
  • Ramírez, Julia
  • Kenttä, Tuomas
  • Junttila, Juhani
  • Kiviniemi, Antti
  • Perkiömäki, Juha
  • Huikuri, Heikki
  • Pueyo, Esther
  • Laguna, Pablo
Objetive: This study aims to evaluate the QT adaptation time following gradual heart rate changes estimated from exercise stress test (EST) ECGs as a marker of sudden cardiac death (SCD) risk. The predicted risk value for any cardiovascular death (CVD) is also evaluated. Methods: Three ECG-derived markers related to QT-RR adaptation time were estimated during the exercise phase of EST, τe, during the recovery phase, τr, and as the difference between them, Δτ. The values were computed from patients with coronary artery disease (CAD) from ARTEMIS study (N=1472; median follow-up of 8.9 years). These markers are calculated as the delay between the observed RR interval series and a patient-specific memoryless RR series computed from the QT interval (RR-based strategy). Alternatively, the estimates were calculated as the delay between the observed QT intervals and a patient-specific instantaneous QT series computed from the RR intervals (QT-based strategy). The relation between the markers and CAD or SCD was evaluated. Results: The marker τr is more robustly estimateed with the RR-based strategy and is able to stratify survivors and victims of either SCD or CVD (p-value equal to 0.022 and 0.065, respectively). Multivariable regression models for predicting SCD and CVD include the QT-RR adaptation time estimated in the recovery phase of EST using the RR-based strategy. Conclusion: A prolonged QT-RR adaptation time during the recovery phase of the EST ECG, calculated with the RR-based strategy, can predict SCD and CVD, providing complementary information to other clinical markers
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

T-wave Peak-to-End Changes, Quantified by Time-Warping, Surrogates Ventricular Repolarization Dispersion for Ventricular Fibrillation Prediction in a Porcine Myocardial Infarction Model

  • Gómez, Neurys
  • Abramochkina, Alena S.
  • Ramírez, Julia
  • Ovechkin, Alexey O.
  • Bernikova, Olesya G.
  • Platonov, Pyotr G.
  • Azarov, Jan E.
  • Laguna, Pablo
  • Martínez, Juan Pablo
Background: Ventricular fibrillation (VF) during acute ischemia is linked to increased dispersion of ventricular repolarization (DOR), which is considered a robust marker of arrhythmic susceptibility. In previous works, we showed that a time-warping-based index quantifying morphological changes from the T-wave peak to the T-wave end over a PCA transform lead, dPCAw,Tpe, outperformed the T-peak-to-T-end interval (Tpe) in arrhythmic risk prediction in a closed-chest porcine infarction model. In this study, we compare dPCAw,Tpe with the DOR measured in an open-chest porcine infarction model, to test the hypothesis that dPCAw,Tpe is a noninvasive surrogate for DOR, investigating its predictive value for VF occurrence. Methods: Myocardial ischemia was induced by coronary ligation in 55 domestic pigs. Surface ECG and intramyocardial electrograms were recorded simultaneously. DOR was computed as the range of the end-of-repolarization times across intramyocardial electrograms, while dPCAw,Tpe was extracted from Tpe morphology, measured in a spatially transformed PCA lead and using a warping-based approach. Additionally, the classical Tpe interval was computed as a reference. Indices were compared between pigs developing delayed VF (Delayed-VF group) and those who did not (Non-VF group). Results: dPCAw,Tpe, DOR and Tpe remained stable at baseline but showed progressive changes during ischemia, with larger changes in animals that developed VF. At 5, 10, and 15 minutes after occlusion, ROC analysis showed significant discriminatory capacity, with AUC values consistently ≥0.79 for all indexes and an early predictive value with AUC of 0.870 for dPCAw,Tpe at 5 minutes, accompanied by balanced sensitivity and specificity values. Cox regression for VF risk prediction resulted in hazard ratios ranging from 5.86 to 11.95 across time points. Kaplan-Meier survival curves stratified by ROC-derived thresholds showed significant separation between groups at all three time points. Linear regression analyses between dPCAw,Tpe and DOR showed consistent correlation in VF-susceptible animals (median R2=0.33). This association was stronger than that observed between Tpe and DOR (median R2=0.16). Conclusions: The time-warping-based index, dPCAw,Tpe, is a reliable non-invasive surrogate of DOR, with comparable predictive value for delayed VF risk under ischemic conditions, providing earlier and more robust prediction than the Tpe index. These findings highlight their translational potential and require validation in human cohort studies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Risk Stratification of Patients With Type 2 Long‐QT Syndrome Through Analysis of T‐Wave Morphology

  • Gómez, Neurys
  • Ramírez, Julia
  • Savelev, Aleksei A.
  • Dahlberg, Pia
  • Svensson, Anneli
  • Larsson, Nina
  • Ljungström, Erik
  • Chaudhry, Uzma
  • Martínez, Juan Pablo
  • Laguna, Pablo
  • Platonov, Pyotr G.
BACKGROUND: Risk stratification in type 2 long-QT syndrome remains challenging, as QT duration may not fully reflect all underlying arrhythmic vulnerability. We assessed whether an index derived from the T-wave morphology is associated with cardiac events in a cohort with type 2 long-QT syndrome. METHODS: We retrospectively and prospectively analyzed 54 genotype-confirmed patients with type 2 long-QT syndrome. T-wave morphology in 8 independent leads was assessed using a warping-based index, the T-wave morphology variation (TMV) index, quantifying T-wave morphologic changes from a general population-based reference T-wave. Association with the first lifetime occurrence of a cardiac event, including either syncope or the combined ventricular arrhythmia end point, was tested using univariate and multivariable Cox regression models. RESULTS: Using the 25th-percentile threshold (TMV≤−18.41 ms), more negative TMV values indicating greater morphologic changes and a broader or delayed repolarization phase in the T-wave signal relative to the control, as observed in lead I, were significantly associated with increased risk of cardiac event (hazard ratio [HR], 3.505 [95% CI, 1.673–7.341]; P<0.001). The association remained significant after adjustment for corrected QT (HR, 2.92 [95% CI, 1.111–7.676]; P=0.03) and after additional adjustment for sex (HR, 3.375 [95% CI, 1.256–9.067]; P=0.016), and the T-wave morphology combination score (HR, 4.061 [95% CI, 1.369–12.046]; P=0.012). CONCLUSIONS: T-wave morphology abnormalities, quantified using TMV, are associated with a higher risk of cardiac events after adjustment for corrected QT prolongation, sex, and morphology combination score. TMV could complement current risk stratification strategies, although confirmatory validation in larger, independent, prospective cohorts is pending.